News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,157 Results
Type
Article (88738)
Company Profile (816)
Press Release (793580)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233574)
Career Advice (4161)
Deals (39981)
Drug Delivery (177)
Drug Development (91685)
Employer Resources (207)
FDA (18548)
Job Trends (17484)
News (398690)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
Adcomms (40)
Allergies (192)
Alliances (56989)
ALS (234)
Alzheimer's disease (1961)
Antibody-drug conjugate (ADC) (546)
Approvals (18877)
Artificial intelligence (855)
Autoimmune disease (348)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (247)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6509)
Cardiovascular disease (547)
Career advice (3596)
Career pathing (52)
CAR-T (380)
CDC (76)
Celiac Disease (3)
Cell therapy (1058)
Cervical cancer (53)
Clinical research (78877)
Collaboration (2339)
Company closure (8)
Compensation (1486)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1263)
Cystic fibrosis (166)
Data (8559)
Decentralized trials (3)
Denatured (90)
Depression (191)
Dermatology (96)
Diabetes (664)
Diagnostics (7580)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (417)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102470)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138426)
Executive appointments (1185)
FDA (22574)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1915)
Gene editing (269)
Generative AI (89)
Gene therapy (845)
GLP-1 (1262)
Government (5556)
Grass and pollen (8)
Guidances (419)
Healthcare (21244)
HIV (92)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (111)
Immunology and inflammation (351)
Immuno-oncology (114)
Indications (201)
Infectious disease (3433)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (313)
Interviews (821)
IPO (17997)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (867)
Lymphoma (459)
Machine learning (65)
Management (66)
Manufacturing (1202)
MASH (221)
Medical device (15261)
Medtech (15407)
Mergers & acquisitions (23261)
Metabolic disorders (1761)
mRNA (263)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (499)
Neuropsychiatric disorders (126)
Neuroscience (3683)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5141)
Now hiring (80)
Obesity (844)
Opinion (371)
Ovarian cancer (242)
Pain (281)
Pancreatic cancer (342)
Parkinson's disease (411)
Partnered (39)
Patents (644)
Patient recruitment (732)
Peanut (69)
People (67928)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24380)
Phase 2 (34262)
Phase 3 (25763)
Pipeline (9565)
Policy (395)
Postmarket research (3559)
Preclinical (10956)
Press Release (72)
Prostate cancer (341)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1242)
Real estate (7462)
Recruiting (81)
Regulatory (30316)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (232)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1299)
Venture capital (131)
Weight loss (578)
Women's health (138)
Worklife (24)
Date
Today (158)
Last 7 days (806)
Last 30 days (3612)
Last 365 days (33152)
2026 (15517)
2025 (33221)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52238)
Australia (9186)
California (14247)
Canada (3981)
China (1540)
Colorado (610)
Connecticut (634)
Delaware (439)
Europe (120466)
Florida (2111)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1232)
India (101)
Indiana (659)
Iowa (25)
Japan (581)
Kansas (143)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1734)
Massachusetts (10411)
Michigan (421)
Minnesota (794)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3774)
New Mexico (35)
New York (3747)
North Carolina (1922)
North Dakota (11)
Northern California (7069)
Ohio (442)
Oklahoma (26)
Oregon (55)
Pennsylvania (2818)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5590)
Tennessee (224)
Texas (2312)
United States (50965)
Utah (425)
Vermont (1)
Virginia (362)
Washington D.C. (89)
Washington State (1172)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,157 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Massachusetts’ life sciences employment dipped last year following 14 years of growth: report
Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting industry employment will increase 9.7% by 2030. It also noted reskilling needs for some roles, including scientists.
June 4, 2026
·
2 min read
·
Angela Gabriel
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.
June 4, 2026
·
2 min read
·
Nick Paul Taylor
IPO
Peptide biotech Parabilis targets up to $476M IPO
Parabilis Medicines is joining the parade of biotechs going public, sharing plans to raise as much as $476.4 million to help advance its lead cancer candidate into late-stage testing.
June 4, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
June 4, 2026
·
9 min read
Press Releases
Quoin Pharmaceuticals Announces Japan’s MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
June 4, 2026
·
6 min read
Press Releases
Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
June 4, 2026
·
2 min read
Press Releases
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
June 4, 2026
·
5 min read
Lymphoma
ADC Therapeutics nosedives on 27 deaths in confirmatory trial for lymphoma drug
In addition to a high rate of deaths, ADC Therapeutics’ Zynlonta plus rituximab showed no overall survival benefit in patients with diffuse large B cell lymphoma, casting doubt on its value as a second-line treatment in this indication.
June 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
June 4, 2026
·
14 min read
Press Releases
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
June 4, 2026
·
1 min read
1 of 88,316
Next
